March 16, 2018
Rose
Opternative, a Chicago-based purveyor of online and mobile refractive eye exams, received a warning letter from the FDA last fall. The October 30 warning letter was only recently made public by the agency.
from MobiHealthNews http://ift.tt/2IuWoBN
March 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Tyto Care raises $25M to continue telehealth device rollout- Judge dismisses Opternative's suit against South Carolina eye care law
- HIMSS Precision Medicine Summit — Call for Speaking Proposals Open
- Outcome Health CEO steps down as part of settlement with investors
- Compliance analytics startup Protenus lands $11M
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment